| Name | Sector |
Revenue
$mlns |
M&A Activity | Last 5 Years | ||
|---|---|---|---|---|---|---|
| Total | Buy | Sell | ||||
London Stock Exchange : GSK Brentford, United Kingdom website |
Life Science | 48,300 | 59 | 35 | 24 |
|
NASDAQ : AZN Cambridge, United Kingdom website |
Life Science | 54,073 | 34 | 23 | 11 |
|
|
QinetiQ
London Stock Exchange : QQ Farnborough, United Kingdom website |
Life Science | 2,974 | 27 | 16 | 11 |
|
|
Mallinckrodt
Public Dublin, United Kingdom website |
Life Science | 2,208 | 20 | 13 | 7 |
|
|
Midatech Pharma
NASDAQ : MTP Cardiff, United Kingdom website |
Life Science | 12 | 4 | 3 | 1 |
|
|
4D pharma
London Stock Exchange : DDDD Leeds, United Kingdom website |
Life Science | - | 2 | 2 | - |
|
|
Clywedog Therapeutics
NASDAQ : CLYD Didcot, United Kingdom website |
Life Science | 15 | 2 | 2 | - |
|
|
DeepMatter Group
London Stock Exchange : DMTR Bristol, United Kingdom website |
Life Science | 2 | 2 | 2 | - |
|
|
Novacyt
Euronext : ALNOV Vélizy-Villacoublay, United Kingdom website |
Life Science | 31 | 2 | 2 | - |
|
|
4basebio
London Stock Exchange : 4BB Cambridge, United Kingdom website |
Life Science | 2 | 1 | 1 | - |
|
|
Animalcare Group
London Stock Exchange : ANCR York, United Kingdom website |
Life Science | 114 | 2 | 1 | 1 |
|
|
Akari Therapeutics
NASDAQ : AKTX London, United Kingdom website |
Life Science | - | 1 | 1 | - |
|
|
Plandai Biotechnology
Public London, United Kingdom website |
Life Science | - | 1 | 1 | - |
|
|
Mereo BioPharma Group
NASDAQ : MREO London, United Kingdom website |
Life Science | 15 | 1 | 1 | - |
|
|
e-Therapeutics
London Stock Exchange : ETX London, United Kingdom website |
Life Science | - | 1 | 1 | - |
|
|
Exscientia
NASDAQ : EXAI Oxford, United Kingdom website |
Life Science | 31 | 1 | 1 | - |
|
Mergr was built to make it easy to understand who owns which companies — and how they got there.
Whether you're researching private equity-backed businesses, recent acquisitions, or potential targets, Mergr provides structured access to thousands of companies, investors, and ownership histories.
The platform is powerful but easy to use — so you can quickly surface relevant companies and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.